News

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...
UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...
Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...
Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...
AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...
ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...
A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.
Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.
A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...
Identifying a key protein’s role could improve the common mental health medications and point to new treatments for inflammation-related diseases, VCU medicinal chemist Youzhong Guo says.
Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...